% | $
Quotes you view appear here for quick access.

Neptune Technologies & Bioressources, Inc. Message Board

  • halspeak halspeak Jan 7, 2013 7:23 PM Flag

    Acasti Pharma, 62% owned subsidiary

    Started trading on Nasdaq today.. ACST .. Check it out.. NEPT has a ways to go to show Acasti valuation..

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ACST has a market cap of ~ $171M of which Neptune owns $106M. Add the $42M NEPT has in cash and compare that ($148M) to their existing market cap of $117M. From there you start to see the value. Once you include their portfolio of patents and growth in Krill sales (to continue in 6 months) it should be obvious that this is a GREAT value. I think investors in the future are going to day dream about the prices we are seeing today.. GLTA

      Sentiment: Strong Buy

1.21-0.01(-0.82%)2:32 PMEDT